TANG CAPITAL MANAGEMENT LLC Q4 2023 Filing

Filed February 14, 2024

Portfolio Value

$1.1T

Holdings

123

Report Date

Q4 2023

Filing Type

13F-HR

All Holdings (123 positions)

#StockSharesValue% PortfolioType
101
NKTREURNEKTAR THERAPEUTICS
2,348,109$1.3B0.12%
102
AREALEXANDRIA REAL ESTATE EQ IN
10,000$1.3B0.12%
103
DTILPRECISION BIOSCIENCES INC
3,400,000$1.2B0.11%
104
MASS908 DEVICES INC
100,000$1.1B0.10%
105
VNDAVANDA PHARMACEUTICALS INC
248,190$1.0B0.10%
106
ABOSACUMEN PHARMACEUTICALS INC
246,895$948.1M0.09%
107
TSPHTUSIMPLE HLDGS INC
1,000,000$877.8M0.08%
108
GOSSGOSSAMER BIO INC
838,600$765.2M0.07%
109
ATYRATYR PHARMA INC
471,134$664.3M0.06%
110
SYRSSYROS PHARMACEUTICALS INC
85,031$662.4M0.06%
111
EGRXEAGLE PHARMACEUTICALS INC
118,857$621.6M0.06%
112
STIMNEURONETICS INC
200,000$580.0M0.05%
113
STELSTELLAR BANCORP INC
20,000$556.8M0.05%
114
NXTCNEXTCURE INC
467,922$533.4M0.05%
115
MOLNMOLECULAR PARTNERS AG
100,000$418.0M0.04%
116
TRVITREVI THERAPEUTICS INC
300,000$402.0M0.04%
117
XERSXERIS BIOPHARMA HOLDINGS INC
150,000$352.5M0.03%
118
ERASERASCA INC
150,000$319.5M0.03%
119
KZRKEZAR LIFE SCIENCES INC
306,665$290.5M0.03%
120
EQEQUILLIUM INC
400,000$289.2M0.03%
121
SELBUSDCARTESIAN THERAPEUTICS INC
400,000$275.8M0.03%
122
WGSGENEDX HOLDINGS CORP
63,636$175.0M0.02%
123
TLPHACELRX PHARMACEUTICALS INC
195,000$143.3M0.01%
PreviousPage 2 of 2